News

As a healthcare executive you may not conduct research or administer medications, but you can still play an important role in helping improve treatment for lymphoma as well as other blood cancers.  Here are five areas in which you can make an impact.

If you’re not asking the right questions, your healthcare organization could be missing out. Here are five questions every healthcare organization should be asking.

A lymphoma expert from the Allegheny Health Network Cancer Institute reveals the status of current and pipeline lymphoma treatments and the three new treatments healthcare executives need to keep on their radar.

Recommendations focus on ways to prevent opioid misuse and reduce risk of addiction.

How one public trust healthcare system overhauled its overall compensation program and successfully transformed its financial operations.

Reference pricing models are emerging as increasingly popular approaches for lowering drug costs.

A first-of-its kind study examined the association between using medication to treat OUD and mortality in patients who had a nonfatal opioid overdose.

New Cardinal Health Specialty Solutions research shares inside information about oncologists’ views about targeted therapies.

FDA’s approval of a cannabidiol (CBD) medicine to treat seizures associated with 2 severe forms of epilepsy is a positive sign for other CBD drugs under development.

The law opens up new options for terminally ill patients. But how will it impact managed care organizations?

FDA’s plan to evaluate gene therapies’ impact on surrogate end points is amping up concerns among payers. Here’s why

Cambia Health Solutions’ Laurent Rotival, MS, reveals what can happen when Amazon’s principles muscle in on the traditional healthcare model.

Trust in the healthcare sector is dropping, a warning sign to executives. Here’s four ways how to reclaim it.

From the frontlines of healthcare, Sarah Krevans, MBA, MPH, Sutter Health, offers AHIP attendees her ideas on healthcare transformation, future outlook, and consumer empowerment.

Trepidation by providers to take on more risk is threatening the road to value-based care.

Benefit cuts and increasing prices are creating medical debt and bankruptcies. Some consumers respond by avoiding healthcare or abandoning coverage. Their alternative? They don’t pay providers.

Joslin Diabetes Center researchers reveal startling study results linking decades of having type 1 diabetes and mental abilities.

A new study has revealing findings about the link between stress at work and heart disease and diabetes.

A new Accenture study reveals how the aggressive adoption of artificial intelligence plays a greater role in healthcare decision making.

To identify the top managed care pharmacy challenges and what your peers are doing about them, Managed Healthcare Executive conducted its annual pharmacy survey during the first quarter of 2018.  

A new annual report from PwC as reveals how employers struggle to contain employee coverage costs.

The manufacturer of bevacizumab (Avastin), snagged FDA approval for yet another type of cancer.

The right technology will enable increased population health efficiencies while simultaneously reducing the resource burden associated with managing that effort. Here are three specific capabilities to look for.